Estrogen biology: New insights into GPER function and clinical opportunities

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 71-83

  Prossnitz, Eric R ^a   Barton, Matthias ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

17 Estradiol; Cardiac; Cardiovascular; GPR30; Immune; SERM

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; G PROTEIN COUPLED RECEPTOR 30; GLUCOCORTICOID RECEPTOR; LIGAND; MINERALOCORTICOID RECEPTOR; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID RECEPTOR; VITAMIN D RECEPTOR; G PROTEIN COUPLED RECEPTOR;

CARDIOVASCULAR SYSTEM; DRUG EFFECT; DRUG MECHANISM; HORMONE ACTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; KNOCKOUT MOUSE; MOLECULAR IMAGING; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM;

ANIMALS; ESTROGENS; HUMANS; LIGANDS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84901491003     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.02.002     Document Type: Review

References (225)

1. Abdelhamid R., Luo J., Vandevrede L., Kundu I., Michalsen B., Litosh V.A., Schiefer I.T., Gherezghiher T., Yao P., Qin Z., Thatcher G.R. Benzothiophene selective estrogen receptor modulators provide neuroprotection by a novel GPR30-dependent mechanism. ACS Chem. Neurosci. 2011, 2:256-268.
2. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Ando S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
3. Albanito L., Lappano R., Madeo A., Chimento A., Prossnitz E.R., Cappello A.R., Dolce V., Abonante S., Pezzi V., Maggiolini M. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ. Health Perspect. 2008, 116:1648-1655.
4. Alexander S.P., Mathie A., Peters J.A. Guide to Receptors and Channels (GRAC), fifth ed. Br. J. Pharmacol. 2011, 164(Suppl. 1). S1-324.
5. Anbalagan M., Huderson B., Murphy L., Rowan B.G. Post-translational modifications of nuclear receptors and human disease. Nucl. Recept. Signal 2012, 10:e001.
6. Banerjee S., Chambliss K.L., Mineo C., Shaul P.W. Recent insights into non-nuclear actions of estrogen receptor alpha. Steroids 2013, [Epub ahead of print].
7. Bartella V., De Marco P., Malaguarnera R., Belfiore A., Maggiolini M. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. Cell. Signal. 2012, 24:1515-1521.
8. Barton M. Position paper: the membrane estrogen receptor GPER - clues and questions. Steroids 2012, 77:935-942.
9. Barton M. Cholesterol and atherosclerosis: modulation by oestrogen. Curr. Opin. Lipidol. 2013, 24:214-220.
10. Barton M. Prevention and endothelial therapy of coronary artery disease. Curr. Opin. Pharmacol. 2013, 13:226-241.
11. Barton M., Minotti R., Haas E. Inflammation and atherosclerosis. Circ. Res. 2007, 101:750-751.
12. Barton M., Meyer M.R., Prossnitz E.R. Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. J. Cardiovasc. Pharmacol. 2013, 62:22-25.
13. Belton O., Fitzgerald D.J. Cyclooxygenase isoforms and atherosclerosis. Expert Rev. Mol. Med. 2003, 5:1-18.
14. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
15. Blasko E., Haskell C.A., Leung S., Gualtieri G., Halks-Miller M., Mahmoudi M., Dennis M.K., Prossnitz E.R., Karpus W.J., Horuk R. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J. Neuroimmunol. 2009, 214:67-77.
16. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2:207-212.
17. Bonds R.S., Midoro-Horiuti T. Estrogen effects in allergy and asthma. Curr. Opin. Allergy Clin. Immunol. 2013, 13:92-99.
18. Bopassa J.C., Eghbali M., Toro L., Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2010, 298. H16-23.
19. Bopassa J.C., Leeb-Lundberg L.F., Olde B., Toro L., Stefani E. Loss of rapid estrogen-induced cardioprotection in GPER-/- mice after ischemia and reperfusion. Biophys. J. 2011, 100:294a-295a. (abstract).
20. Bopassa J.C., Lu R., Singh H., Olde B., Krust A., Leeb-Lundberg L.F., Toro L., Stefani E. G protein-coupled Estrogen Receptor 1, but not Estrogen Receptors alpha and beta, mediates rapid estrogen-induced cardioprotection during ischemia/reperfusion Iinjury in male mice. Biophys. J. 2012, 102:141a. (abstract).
21. Bopassa J.C., Lu R., Singh H., Zilberstein N.F., Olde B., Krust A., Leeb-Lundberg L.F., Toro L., Stefani E. Rapid activation of G protein-coupled Estrogen Receptor 1 protects the heart against ischemia-reperfusion injury by inhibiting the mPTP opening via PKC/AKT/ERK/GSK-3b pathways. Circ. Res. 2012, 111:A213. (abstract).
22. Bopassa J.C., Lu R., Singh H., Olde B., Leeb-Lundberg L.F., Toro L., Stefani E. Identification of mitochondrial proteins regulated during activation of GPER1-leading to cardioprotection. Biophys. J. 2013, 104:657a. (abstract).
23. Borjesson A.E., Windahl S.H., Lagerquist M.K., Engdahl C., Frenkel B., Moverare-Skrtic S., Sjogren K., Kindblom J.M., Stubelius A., Islander U., Antal M.C., Krust A., Chambon P., Ohlsson C. Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:6288-6293.
24. Bouschet T., Martin S., Henley J.M. Regulation of calcium sensing receptor trafficking by RAMPs. Adv. Exp. Med. Biol. 2012, 744:39-48.
25. Brailoiu G.C., Arterburn J.B., Oprea T.I., Chitravanshi V.C., Brailoiu E. Bradycardic effects mediated by activation of G protein-coupled estrogen receptor (GPER) in rat nucleus ambiguus. Exp. Physiol. 2012, 98:679-691.
26. Brailoiu G.C., Benamar K., Arterburn J.B., Gao E., Rabinowitz J.E., Koch W.J., Brailoiu E. Aldosterone increases cardiac vagal tone via GPER activation. J. Physiol. 2013, epub.
27. Broughton B.R., Brait V.H., Ah Kim H., Lee S., Chu H.X., Gardiner-Mann C.V., Guida E., Evans M.A., Miller A.A., Arumugam T.V., Drummond G.R., Sobey C.G. Sex-dependent effects of g protein-coupled estrogen receptor activity on outcome after ischemic stroke. Stroke 2014, epub.
28. Brunsing R.L., Prossnitz E.R. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology 2011, 134:93-106.
29. Brunsing R.L., Owens K.S., Prossnitz E.R. The G protein-coupled estrogen receptor (GPER) agonist G-1 expands the regulatory T-cell population under TH17-polarizing conditions. J. Immunother. 2013, 36:190-196.
30. Burai R., Ramesh C., Nayak T., Dennis M.K., Bryant B., Prossnitz E.R., Arterburn J.B. Synthesis and characterization of tricarbonyl-Re/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER/GPR30. PLoS ONE 2012, 7:e46861.
31. Cabas I., Rodenas M.C., Abellan E., Meseguer J., Mulero V., Garcia-Ayala A. Estrogen signaling through the G protein-coupled estrogen receptor regulates granulocyte activation in fish. J. Immunol. 2013, 191:4628-4639.
32. Carmeci C., Thompson D.A., Ring H.Z., Francke U., Weigel R.J. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997, 45:607-617.
33. Chakrabarti S., Davidge S.T. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. PLoS ONE 2012, 7:e52357.
34. Chakrabarti S., Morton J.S., Davidge S.T. Mechanisms of estrogen effects on the endothelium: an overview. Can. J. Cardiol. 2013, [Epub ahead of print].
35. Chambliss K.L., Wu Q., Oltmann S., Konaniah E.S., Umetani M., Korach K.S., Thomas G.D., Mineo C., Yuhanna I.S., Kim S.H., Madak-Erdogan Z., Maggi A., Dineen S.P., Roland C.L., Hui D.Y., Brekken R.A., Katzenellenbogen J.A., Katzenellenbogen B.S., Shaul P.W. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 2010, 120:2319-2330.
36. Cheng S.B., Graeber C.T., Quinn J.A., Filardo E.J. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 2011, 76:892-896.
37. Cheng S.B., Quinn J.A., Graeber C.T., Filardo E.J. Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J. Biol. Chem. 2011, 286:22441-22455.
38. Cheng S.B., Dong J., Pang Y., Larocca J., Hixon M., Thomas P., Filardo E.J. Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. Mol. Cell. Endocrinol. 2013, 382:950-959.
39. Chevalier N., Bouskine A., Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int. J. Cancer 2012, 130:241-242.
40. Chevalier N., Paul-Bellon R., Camparo P., Michiels J.F., Chevallier D., Fenichel P. Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma. Int. J. Mol. Sci. 2014, 15:1574-1589.
41. Chimento A., Casaburi I., Rosano C., Avena P., De Luca A., Campana C., Martire E., Santolla M.F., Maggiolini M., Pezzi V., Sirianni R. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol. Nutr. Food Res. 2013, epub.
42. Corcoran J.J., Nicholson C., Sweeney M., Charnock J.C., Robson S.C., Westwood M., Taggart M.J. Human uterine and placental arteries exhibit tissue-specific acute responses to 17beta-oestradiol and oestrogen-receptor specific agonists. Mol. Hum. Reprod. 2014, [Epub ahead of print].
43. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379:557-560.
44. De Francesco E.M., Lappano R., Santolla M.F., Marsico S., Caruso A., Maggiolini M. HIF-1alpha/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). Breast Cancer Res. 2013, 15:R64.
45. Dennis M.K., Burai R., Ramesh C., Petrie W.K., Alcon S.N., Nayak T.K., Bologa C.G., Leitao A., Brailoiu E., Deliu E., Dun N.J., Sklar L.A., Hathaway H.J., Arterburn J.B., Oprea T.I., Prossnitz E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5:421-427.
46. Dennis M.K., Field A.S., Burai R., Ramesh C., Petrie W.K., Bologa C.G., Oprea T.I., Yamaguchi Y., Hayashi S., Sklar L.A., Hathaway H.J., Arterburn J.B., Prossnitz E.R. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J. Steroid Biochem. Mol. Biol. 2011, 127:358-366.
47. Deschamps A.M., Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 2009, 297. H1806-1813.
48. Ding Q., Gros R., Limbird L.E., Chorazyczewski J., Feldman R.D. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR30. Am. J. Physiol. Cell Physiol. 2009, 297. C1178-1187.
49. Dong S., Terasaka S., Kiyama R. Bisphenol A induces a rapid activation of Erk1/2 through GPR30 in human breast cancer cells. Environ. Pollut. 2011, 159:212-218.
50. Dong W.H., Chen J.C., He Y.L., Xu J.J., Mei Y.A. Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. Am. J. Physiol. Cell Physiol. 2013, 305. C547-557.
51. Dripps D.J., Brandhuber B.J., Thompson R.C., Eisenberg S.P. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J. Biol. Chem. 1991, 266:10331-10336.
52. Dufau M.L. The luteinizing hormone receptor. Annu. Rev. Physiol. 1998, 60:461-496.
53. Durusu Tanriover M., Bora Tatar G., Uluturk T.D., Dayangac Erden D., Tanriover A., Kilicarslan A., Oz S.G., Erdem Yurter H., Sozen T., Sain Guven G. Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women. Clin. Rheumatol. 2010, 29:1285-1293.
54. Edwards D.P. Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 2005, 67:335-376.
55. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol. Rev. 2000, 52:513-556.
56. Faulds M.H., Zhao C., Dahlman-Wright K., Gustafsson J.A. The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J. Endocrinol. 2012, 212:3-12.
57. Feldman R.D., Gros R., Hegele R.A., Ding Q., Hussain Y., Ban M.R., McIntyre A.D. A common hypofunctional genetic variant of GPER: increased blood pressure in female carriers and increased expression in female hypertensive patients. Hypertension 2013, 62:A352.
58. Feng Y., Gregor P. Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem. Biophys. Res. Commun. 1997, 231:651-654.
59. Filardo E.J., Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 2012, 153:2953-2962.
60. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
61. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
62. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. 2010, 459:793-806.
63. Ford J., Hajibeigi A., Long M., Hahner L., Gore C., Hsieh J.T., Clegg D., Zerwekh J., Oz O.K. GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. J. Bone Miner. Res. 2011, 26:298-307.
64. Fowler A.M. A molecular approach to breast imaging. J. Nucl. Med. 2014.
65. Frangogiannis N.G. Targeting the inflammatory response in healing myocardial infarcts. Curr. Med. Chem. 2006, 13:1877-1893.
66. Fraser S.P., Ozerlat-Gunduz I., Onkal R., Diss J.K., Latchman D.S., Djamgoz M.B. Estrogen and non-genomic upregulation of voltage-gated Na(+) channel activity in MDA-MB-231 human breast cancer cells: role in adhesion. J. Cell. Physiol. 2010, 224:527-539.
67. Fu X.D., Simoncini T. Extra-nuclear signaling of estrogen receptors. IUBMB Life 2008, 60:502-510.
68. Funder J.W. Medicine. The genetics of primary aldosteronism. Science 2011, 331:685-686.
69. Gao F., Ma X., Ostmann A.B., Das S.K. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and Estrogen Receptor Alpha (ER{alpha}) phosphorylation signals. Endocrinology 2011.
70. Golias C., Tsoutsi E., Matziridis A., Makridis P., Batistatou A., Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 2007, 21:757-769.
71. Goswami C., Kuhn J., Dina O.A., Fernandez-Ballester G., Levine J.D., Ferrer-Montiel A., Hucho T. Estrogen destabilizes microtubules through an ion-conductivity-independent TRPV1 pathway. J. Neurochem. 2011, 117:995-1008.
72. Green S., Walter P., Greene G., Krust A., Goffin C., Jensen E., Scrace G., Waterfield M., Chambon P. Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 1986, 24:77-83.
73. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986, 231:1150-1154.
74. Gros R., Ding Q., Sklar L.A., Prossnitz E.E., Arterburn J.B., Chorazyczewski J., Feldman R.D. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011, 57:442-451.
75. Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304. C532-540.
76. Haas E., Meyer M.R., Schurr U., Bhattacharya I., Minotti R., Nguyen H.H., Heigl A., Lachat M., Genoni M., Barton M. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 2007, 49:1358-1363.
77. Haas E., Bhattacharya I., Brailoiu E., Damjanovic M., Brailoiu G.C., Gao X., Mueller-Guerre L., Marjon N.A., Gut A., Minotti R., Meyer M.R., Amann K., Ammann E., Perez-Dominguez A., Genoni M., Clegg D.J., Dun N.J., Resta T.C., Prossnitz E.R., Barton M. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ. Res. 2009, 104:288-291.
78. Han G., Li F., Yu X., White R.E. GPER: a novel target for non-genomic estrogen action in the cardiovascular system. Pharmacol. Res. 2013, 71:53-60.
79. Haynes M.P., Li L., Russell K.S., Bender J.R. Rapid vascular cell responses to estrogen and membrane receptors. Vasc. Pharmacol. 2002, 38:99-108.
80. Heino T.J., Chagin A.S., Savendahl L. The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone. J. Endocrinol. 2008, 197. R1-6.
81. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
82. Ho M.K., Su Y., Yeung W.W., Wong Y.H. Regulation of transcription factors by heterotrimeric G proteins. Curr. Mol. Pharmacol. 2009, 2:19-31.
83. Hofmeister M.V., Damkier H.H., Christensen B.M., Olde B., Fredrik Leeb-Lundberg L.M., Fenton R.A., Praetorius H.A., Praetorius J. 17Beta-estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1. Am. J. Physiol. Renal Physiol. 2012, 302. F358-368.
84. Holm A., Nilsson B.O. Identification and characterization of new mechanisms in vascular oestrogen signalling. Basic Clin. Pharmacol. Toxicol. 2013, 113:287-293.
85. Holm A., Baldetorp B., Olde B., Leeb-Lundberg L.M., Nilsson B.O. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J. Vasc. Res. 2011, 48:327-335.
86. Holm A., Hellstrand P., Olde B., Svensson D., Leeb-Lundberg L.M., Nilsson B.O. The G protein-coupled estrogen receptor 1 (GPER1/GPR30) agonist G-1 regulates vascular smooth muscle cell Ca(2)(+) handling. J. Vasc. Res. 2013, 50:421-429.
87. Huryn D.M., Resnick L.O., Wipf P. Contributions of academic laboratories to the discovery and development of chemical biology tools. J. Med. Chem. 2013, 56:7161-7176.
88. Hutchens M.P., Fujiyoshi T., Komers R., Herson P.S., Anderson S. Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Renal Physiol. 2012, 303. F377-385.
89. Isensee J., Meoli L., Zazzu V., Nabzdyk C., Witt H., Soewarto D., Effertz K., Fuchs H., Gailus-Durner V., Busch D., Adler T., de Angelis M.H., Irgang M., Otto C., Noppinger P.R. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 2009, 150:1722-1730.
90. Jang E.J., Seok Y.M., Arterburn J.B., Olatunji L.A., Kim I.K. GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway. J. Pharm. Pharmacol. 2013, 65:1488-1499.
91. Kajta M., Rzemieniec J., Litwa E., Lason W., Lenartowicz M., Krzeptowski W., Wojtowicz A.K. The key involvement of estrogen receptor beta and G-protein-coupled receptor 30 in the neuroprotective action of daidzein. Neuroscience 2013, 238:345-360.
92. Kanda N., Watanabe S. 17Beta-estradiol enhances the production of nerve growth factor in THP-1-derived macrophages or peripheral blood monocyte-derived macrophages. J. Invest. Dermatol. 2003, 121:771-780.
93. Kanda N., Watanabe S. 17Beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J. Invest. Dermatol. 2003, 121:1500-1509.
94. Kanda N., Watanabe S. 17Beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J. Invest. Dermatol. 2004, 123:319-328.
95. Kang L., Zhang X., Xie Y., Tu Y., Wang D., Liu Z., Wang Z.Y. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 2010, 24:709-721.
96. Kang S., Liu Y., Sun D., Zhou C., Liu A., Xu C., Hao Y., Li D., Yan C., Sun H. Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure. PLoS ONE 2012, 7:e48185.
97. Kim K.H., Bender J.R. Membrane-initiated actions of estrogen on the endothelium. Mol. Cell. Endocrinol. 2009, 308:3-8.
98. Kim K.H., Toomre D., Bender J.R. Splice isoform estrogen receptors as integral transmembrane proteins. Mol. Biol. Cell 2011, 22:4415-4423.
99. King W.J., Greene G.L. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 1984, 307:745-747.
100. Knowlton A.A., Lee A.R. Estrogen and the cardiovascular system. Pharmacol. Ther. 2012, 135:54-70.
101. Koganti S., Snyder R., Gumaste U., Karamyan V.T., Thekkumkara T. 2-Methoxyestradiol binding of GPR30 down-regulates angiotensin AT receptor. Eur. J. Pharmacol. 2013, 723C:131-140.
102. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5925-5930.
103. Kvingedal A.M., Smeland E.B. A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett. 1997, 407:59-62.
104. Lafferty A.R., Torpy D.J., Stowasser M., Taymans S.E., Lin J.P., Huggard P., Gordon R.D., Stratakis C.A. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J. Med. Genet. 2000, 37:831-835.
105. Lappano R., Rosano C., De Marco P., De Francesco E.M., Pezzi V., Maggiolini M. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol. Cell. Endocrinol. 2010, 320:162-170.
106. Lappano R., Rosano C., Santolla M.F., Pupo M., De Francesco E.M., De Marco P., Ponassi M., Spallarossa A., Ranise A., Maggiolini M. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr. Cancer Drug Targets 2012, 12:531-542.
107. Lappano R., Santolla M.F., Pupo M., Sinicropi M.S., Caruso A., Rosano C., Maggiolini M. MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells. Breast Cancer Res. 2012, 14:R12.
108. Lappano R., De Marco P., De Francesco E.M., Chimento A., Pezzi V., Maggiolini M. Cross-talk between GPER and growth factor signaling. J. Steroid Biochem. Mol. Biol. 2013, 137:50-56.
109. Lenhart P.M., Broselid S., Barrick C.J., Leeb-Lundberg L.M., Caron K.M. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J. Mol. Endocrinol. 2013, 51:191-202.
110. Levin E.R. Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2009, 20:477-482.
111. Li Y., Birnbaumer L., Teng C.T. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Mol. Endocrinol. 2010, 24:969-980.
112. Li Z.L., Liu J.C., Liu S.B., Li X.Q., Yi D.H., Zhao M.G. Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS ONE 2012, 7:e38787.
113. Li F., Yu X., Szynkarski C.K., Meng C., Zhou B., Barhoumi R., White R.E., Heaps C.L., Stallone J.N., Han G. Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PLoS ONE 2013, 8:e64771.
114. Li Y., Chen Y., Zhu Z.X., Liu X.H., Yang L., Wan L., Lei T.W., Wang X.D. 4-Hydroxytamoxifen-stimulated processing of cyclin E is mediated via G protein-coupled receptor 30 (GPR30) and accompanied by enhanced migration in MCF-7 breast cancer cells. Toxicology 2013, 309:61-65.
115. Lin B.C., Suzawa M., Blind R.D., Tobias S.C., Bulun S.E., Scanlan T.S., Ingraham H.A. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res. 2009, 69:5415-5423.
116. Lindsey S.H., Chappell M.C. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen. Gender Med. 2011, 8:343-354.
117. Lindsey S.H., Cohen J.A., Brosnihan K.B., Gallagher P.E., Chappell M.C. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 2009, 150:3753-3758.
118. Lindsey S.H., Yamaleyeva L.M., Brosnihan K.B., Gallagher P.E., Chappell M.C. Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 2011, 58:665-671.
119. Lindsey S.H., da Silva A.S., Silva M.S., Chappell M.C. Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am. J. Physiol. Endocrinol. Metab. 2013, 305. E113-118.
120. Lindsey S.H., Liu L., Chappell M.C. Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling. Steroids 2013.
121. Liu X., Zhu P., Sham K.W., Yuen J.M., Xie C., Zhang Y., Liu Y., Li S., Huang X., Cheng C.H., Lin H. Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPER and its high expression in early germ cells of the testis. Biol. Reprod. 2009, 80:1253-1261.
122. Liu L., Zhao Y., Xie K., Sun X., Gao Y., Wang Z. Estrogen-induced nongenomic calcium signaling inhibits lipopolysaccharide-stimulated Tumor Necrosis Factor alpha production in macrophages. PLoS ONE 2013, 8:e83072.
123. Ma Y., Qiao X., Falone A.E., Reslan O.M., Sheppard S.J., Khalil R.A. Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat. Cell. Physiol. Biochem. 2010, 26:457-470.
124. Madeo A., Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res. 2010, 70:6036-6046.
125. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., Montanaro D., Musti A.M., Picard D., Ando S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004, 279:27008-27016.
126. Mårtensson U.E., Salehi S.A., Windahl S., Gomez M.F., Sward K., Daszkiewicz-Nilsson J., Wendt A., Andersson N., Hellstrand P., Grande P.O., Owman C., Rosen C.J., Adamo M.L., Lundquist I., Rorsman P., Nilsson B.O., Ohlsson C., Olde B., Leeb-Lundberg L.M. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 2009, 150:687-698.
127. Matsuzawa Y., Suematsu S., Saito J., Omura M., Nishikawa T. Vascular aldosterone production at the pre-diabetic stage of young Otsuka Long-Evans Tokushima Fatty (OLETF) rats, compared with Long-Evans Tokushima Otsuka (LETO) rats. Molecules 2013, 18:15636-15647.
128. McCurley A., Pires P.W., Bender S.B., Aronovitz M., Zhao M.J., Metzger D., Chambon P., Hill M.A., Dorrance A.M., Mendelsohn M.E., Jaffe I.Z. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 2012, 18:1429-1433.
129. Meyer M.R., Barton M. ERa, ERb, and gpER: novel aspects of estrogen receptor signaling in atherosclerosis. Cardiovasc. Res. 2009, 83:605-610.
130. Meyer M.R., Haas E., Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 2006, 47:1019-1026.
131. Meyer M.R., Haas E., Prossnitz E.R., Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol. Cell. Endocrinol. 2009, 308:9-16.
132. Meyer M.R., Baretella O., Prossnitz E.R., Barton M. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI182,780. Pharmacology 2010, 86:58-64.
133. Meyer M.R., Clegg D.J., Prossnitz E.R., Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol. (Oxf.) 2011.
134. Meyer M.R., Prossnitz E.R., Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vasc. Pharmacol. 2011, 55:17-25.
135. Meyer M.R., Amann K., Field A.S., Hu C., Hathaway H.J., Kanagy N.L., Walker M.K., Barton M., Prossnitz E.R. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 2012, 59:507-512.
136. Meyer M.R., Field A.S., Kanagy N.L., Barton M., Prossnitz E.R. GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci. 2012, 91:623-627.
137. Meyer M.R., Fredette N.C., Barton M., Prossnitz E.R. Regulation of vascular smooth muscle tone by adipose-derived contracting factor. PLoS ONE 2013, 8:e79245.
138. Miller V.M. Why are sex and gender important to basic physiology, translational and individualized medicine?. Am. J. Physiol. Heart Circ. Physiol. 2014, epub.
139. Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 2013, 13:709-721.
140. Moriarty K., Kim K.H., Bender J.R. Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 2006, 147:5557-5563.
141. Moverare-Skrtic S., Borjesson A.E., Farman H.H., Sjogren K., Windahl S.H., Lagerquist M.K., Andersson A., Stubelius A., Carlsten H., Gustafsson J.A., Ohlsson C. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor alpha AF-2 is modified. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:1180-1185.
142. Mügge A., Riedel M., Barton M., Kuhn M., Lichtlen P.R. Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc. Res. 1993, 27:1939-1942.
143. Murata T., Dietrich H.H., Xiang C., Dacey R.G. G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats. Stroke 2013, 44:779-785.
144. Nayak T.K., Dennis M.K., Ramesh C., Burai R., Atcher R.W., Sklar L.A., Norenberg J.P., Hathaway H.J., Arterburn J.B., Prossnitz E.R. Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111In-labeled nonsteroidal imaging agents. ACS Chem. Biol. 2010, 5:681-690.
145. Niino M., Hirotani M., Fukazawa T., Kikuchi S., Sasaki H. Estrogens as potential therapeutic agents in multiple sclerosis. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9:87-94.
146. Norman P.E., Powell J.T. Vitamin d and cardiovascular disease. Circ. Res. 2014, 114:379-393.
147. O'Brien J.E., Peterson T.J., Tong M.H., Lee E.J., Pfaff L.E., Hewitt S.C., Korach K.S., Weiss J., Jameson J.L. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. J. Biol. Chem. 2006, 281:26683-26692.
148. O'Dowd B.F., Nguyen T., Marchese A., Cheng R., Lynch K.R., Heng H.H., Kolakowski L.F., George S.R. Discovery of three novel G-protein-coupled receptor genes. Genomics 1998, 47:310-313.
149. Offit K. Personalized medicine: new genomics, old lessons. Hum. Genet. 2011, 130:3-14.
150. Orimo A., Inoue S., Ikegami A., Hosoi T., Akishita M., Ouchi Y., Muramatsu M., Orimo H. Vascular smooth muscle cells as target for estrogen. Biochem. Biophys. Res. Commun. 1993, 195:730-736.
151. Otto C., Rohde-Schulz B., Schwarz G., Fuchs I., Klewer M., Brittain D., Langer G., Bader B., Prelle K., Nubbemeyer R., Fritzemeier K.H. GPR30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 2008, 149:4846-4856.
152. Owman C., Blay P., Nilsson C., Lolait S.J. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem. Biophys. Res. Commun. 1996, 228:285-292.
153. Ozdemir V., Williams-Jones B., Glatt S.J., Tsuang M.T., Lohr J.B., Reist C. Shifting emphasis from pharmacogenomics to theragnostics. Nat. Biotechnol. 2006, 24:942-946.
154. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28:523-532.
155. Patel V.H., Chen J., Ramanjaneya M., Karteris E., Zachariades E., Thomas P., Been M., Randeva H.S. G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress. Int. J. Mol. Med. 2010, 26:193-199.
156. Pavlik R., Wypior G., Hecht S., Papadopoulos P., Kupka M., Thaler C., Wiest I., Pestka A., Friese K., Jeschke U. Induction of G protein-coupled estrogen receptor (GPER) and nuclear steroid hormone receptors by gonadotropins in human granulosa cells. Histochem. Cell Biol. 2011, 136:289-299.
157. Pernis A.B. Estrogen and CD4+ T cells. Curr. Opin. Rheumatol. 2007, 19:414-420.
158. Petrie W.K., Dennis M.K., Hu C., Dai D., Arterburn J.B., Smith H.O., Hathaway H.J., Prossnitz E.R. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet. Gynecol. Int. 2013, 2013:472720.
159. Peyton C., Thomas P. Involvement of epidermal growth factor receptor signaling in estrogen inhibition of oocyte maturation mediated through the G protein-coupled estrogen receptor (Gper) in zebrafish (Danio rerio). Biol. Reprod. 2011, 85:42-50.
160. Pietras R.J., Szego C.M. Endometrial cell calcium and oestrogen action. Nature 1975, 253:357-359.
161. Prossnitz E.R., Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat. Rev. Endocrinol. 2011, 7:715-726.
162. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol. Cell. Endocrinol. 2009, 308:32-38.
163. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
164. Prossnitz E.R., Sklar L.A., Oprea T.I., Arterburn J.B. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol. Sci. 2008, 29:116-123.
165. Pruthi D., McCurley A., Aronovitz M., Galayda C., Karumanchi S.A., Jaffe I.Z. Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors. Arterioscler. Thromb. Vasc. Biol. 2014, 34:355-364.
166. Pupo M., Pisano A., Lappano R., Santolla M.F., De Francesco E.M., Abonante S., Rosano C., Maggiolini M. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ. Health Perspect. 2012, 120:1177-1182.
167. Pupo M., Vivacqua A., Perrotta I., Pisano A., Aquila S., Abonante S., Gasperi-Campani A., Pezzi V., Maggiolini M. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs). Mol. Cell. Endocrinol. 2013, 376:23-32.
168. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci. 2003, 23:9529-9540.
169. Qiu J., Ronnekleiv O.K., Kelly M.J. Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor. Steroids 2008, 73:985-991.
170. Quinn J.A., Graeber C.T., Frackelton A.R., Kim M., Schwarzbauer J.E., Filardo E.J. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G-protein-coupled receptor, GPR30. Mol. Endocrinol. 2009, 23:1052-1064.
171. Ramesh C., Nayak T.K., Burai R., Dennis M.K., Hathaway H.J., Sklar L.A., Prossnitz E.R., Arterburn J.B. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30. J. Med. Chem. 2010, 53:1004-1014.
172. Ray A., Ficek M. Immunomodulatory effects of anti-estrogenic drugs. Acta. Pharm. 2012, 62:141-155.
173. Ren J., Wu J.H. 17Beta-estradiol rapidly activates calcium release from intracellular stores via the GPR30 pathway and MAPK phosphorylation in osteocyte-like MLO-Y4 cells. Calcif. Tissue Int. 2012, 90:411-419.
174. Resanovic I., Rizzo M., Zafirovic S., Bjelogrlic P., Perovic M., Savic K., Patti A.M., Isenovic R.E. Anti-atherogenic effects of 17beta-estradiol. Horm. Metab. Res. 2013, 45:701-708.
175. Reslan O.M., Yin Z., do Nascimento G.R., Khalil R.A. Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat. J. Cardiovasc. Pharmacol. 2013, 62:26-40.
176. Rettberg J.R., Yao J., Brinton R.D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front. Neuroendocrinol. 2014, 35:8-30.
177. Rettew J.A., McCall S.H.t., Marriott I. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol. Cell. Endocrinol. 2010, 328:87-92.
178. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
179. Revankar C.M., Mitchell H.D., Field A.S., Burai R., Corona C., Ramesh C., Sklar L.A., Arterburn J.B., Prossnitz E.R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2007, 2:536-544.
180. Ross-Innes C.S., Stark R., Teschendorff A.E., Holmes K.A., Ali H.R., Dunning M.J., Brown G.D., Gojis O., Ellis I.O., Green A.R., Ali S., Chin S.F., Palmieri C., Caldas C., Carroll J.S. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393.
181. Rowlands D.J., Chapple S., Siow R.C., Mann G.E. Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: roles for F-actin and GPR30. Hypertension 2011, 57:833-840.
182. Sakiani S., Olsen N.J., Kovacs W.J. Gonadal steroids and humoral immunity. Nat. Rev. Endocrinol. 2013, 9:56-62.
183. Schiffrin E.L. Vascular mineralocorticoid receptors regulate blood pressure effects on myogenic tone and role in aging. Circ. Res. 2013, 112:415-417.
184. Schultz-Norton J.R., Ziegler Y.S., Nardulli A.M. ERalpha-associated protein networks. Trends Endocrinol. Metab. 2011, 22:124-129.
185. Sharma G., Prossnitz E.R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 2011, 152:3030-3039.
186. Sharma G., Hu C., Brigman J.L., Zhu G., Hathaway H.J., Prossnitz E.R. GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 2013, 154:4136-4145.
187. Shastry B.S. Pharmacogenetics and the concept of individualized medicine. Pharmacogenom. J. 2006, 6:16-21.
188. Sheng Z.G., Huang W., Liu Y.X., Zhu B.Z. Bisphenol A at a low concentration boosts mouse spermatogonial cell proliferation by inducing the G protein-coupled receptor 30 expression. Toxicol. Appl. Pharmacol. 2013, 267:88-94.
189. Smith H.O., Leslie K.K., Singh M., Qualls C.R., Revankar C.M., Joste N.E., Prossnitz E.R. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 2007, 196. 386. e381-311.
190. Smith H.O., Arias-Pulido H., Kuo D.Y., Howard T., Qualls C.R., Lee S.J., Verschraegen C.F., Hathaway H.J., Joste N.E., Prossnitz E.R. GPR30 predicts poor survival for ovarian cancer. Gynecol. Oncol. 2009, 114:465-471.
191. Subramanian S., Miller L.M., Grafe M.R., Vandenbark A.A., Offner H. Contribution of GPR30 for 1,25 dihydroxyvitamin D(3) protection in EAE. Metab. Brain Dis. 2012, 27:29-35.
192. Sukocheva O., Wadham C., Holmes A., Albanese N., Verrier E., Feng F., Bernal A., Derian C.K., Ullrich A., Vadas M.A., Xia P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 2006, 173:301-310.
193. Szego C.M., Davis J.S. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A. 1967, 58:1711-1718.
194. Takada Y., Kato C., Kondo S., Korenaga R., Ando J. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem. Biophys. Res. Commun. 1997, 240:737-741.
195. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
196. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
197. Tiano J.P., Delghingaro-Augusto V., Le May C., Liu S., Kaw M.K., Khuder S.S., Latour M.G., Bhatt S.A., Korach K.S., Najjar S.M., Prentki M., Mauvais-Jarvis F. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. J. Clin. Invest. 2011, 121:3331-3342.
198. Tica A.A., Dun E.C., Tica O.S., Gao X., Arterburn J.B., Brailoiu G.C., Oprea T.I., Brailoiu E. G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. Am. J. Physiol. Cell Physiol. 2011, 301. C1262-1269.
199. Tisdale M.J. Biochemical mechanisms of cellular catabolism. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:401-405.
200. Traupe T., Stettler C.D., Li H., Haas E., Bhattacharya I., Minotti R., Barton M. Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries. Hypertension 2007, 49:1364-1370.
201. van't Veer L.J., Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008, 452:564-570.
202. Venkatakrishnan A.J., Deupi X., Lebon G., Tate C.G., Schertler G.F., Babu M.M. Molecular signatures of G-protein-coupled receptors. Nature 2013, 494:185-194.
203. Vergote I., Abram P. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents. Ann. Oncol. 2006, 17:200-204.
204. Villablanca A.C., Tenwolde A., Lee M., Huck M., Mumenthaler S., Rutledge J.C. 17Beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J. Cardiovasc. Transl. Res. 2009, 2:289-299.
205. Vivacqua A., Bonofiglio D., Albanito L., Madeo A., Rago V., Carpino A., Musti A.M., Picard D., Ando S., Maggiolini M. 17Beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol. Pharmacol. 2006, 70:1414-1423.
206. Vivacqua A., Bonofiglio D., Recchia A.G., Musti A.M., Picard D., Ando S., Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17b-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 2006, 20:631-646.
207. Vivacqua A., Romeo E., De Marco P., De Francesco E.M., Abonante S., Maggiolini M. GPER mediates the Egr-1 expression induced by 17beta-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Res. Treat. 2012, 133:1025-1035.
208. Volpe M., Gigante B., Enea I., Porcellini A., Russo R., Lee M.A., Magri P., Condorelli G., Savoia C., Lindpaintner K., Rubattu S. Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. Circ. Res. 1997, 81:857-864.
209. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 2005, 336:1023-1027.
210. Wang Z., Zhang X., Shen P., Loggie B.W., Chang Y., Deuel T.F. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9063-9068.
211. Wang C., Dehghani B., Magrisso I.J., Rick E.A., Bonhomme E., Cody D.B., Elenich L.A., Subramanian S., Murphy S.J., Kelly M.J., Rosenbaum J.S., Vandenbark A.A., Offner H. GPR30 contributes to estrogen-induced thymic atrophy. Mol. Endocrinol. 2008, 22:636-648.
212. Wang C., Prossnitz E.R., Roy S.K. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 2008, 149:4452-4461.
213. Wang C., Dehghani B., Li Y., Kaler L.J., Proctor T., Vandenbark A.A., Offner H. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J. Immunol. 2009, 182:3294-3303.
214. Wang H., Jessup J.A., Lin M.S., Chagas C., Lindsey S.H., Groban L. Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. Cardiovasc. Res. 2012, 94:96-104.
215. Washburn N., Borgquist A., Wang K., Jeffery G.S., Kelly M.J., Wagner E.J. Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis. Neuroendocrinology 2013, 97:160-175.
216. Weil B.R., Manukyan M.C., Herrmann J.L., Wang Y., Abarbanell A.M., Poynter J.A., Meldrum D.R. Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery 2010, 148:436-443.
217. Weisz A., Bresciani F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol. 1988, 2:816-824.
218. Wu Q., Chambliss K., Umetani M., Mineo C., Shaul P.W. Non-nuclear estrogen receptor signaling in endothelium. J. Biol. Chem. 2011, 286:14737-14743.
219. Yates M.A., Li Y., Chlebeck P.J., Offner H. GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol. 2010, 11:20.
220. Ylikomi T., Vienonen A., Ahola T.M. G protein-coupled receptor 30 down-regulates cofactor expression and interferes with the transcriptional activity of glucocorticoid. Eur. J. Biochem. 2004, 271:4159-4168.
221. Yu X., Ma H., Barman S.A., Liu A.T., Sellers M., Stallone J.N., Prossnitz E.R., White R.E., Han G. Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. Am. J. Physiol. Endocrinol. Metab. 2011, 301. E882-888.
222. Zazzu, V., 2011. The Human G protein-coupled Receptor GPR30: Interaction Partners and Expression Analysis in Endothelial Cells. Dissertation Germany, Humboldt University Berlin, pp. 1-123.
223. Zhang B., Subramanian S., Dziennis S., Jia J., Uchida M., Akiyoshi K., Migliati E., Lewis A.D., Vandenbark A.A., Offner H., Hurn P.D. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J. Immunol. 2010, 184:4087-4094.
224. Zhu P., Yuen J.M., Sham K.W., Cheng C.H. GPER mediates the inhibitory actions of estrogen on adipogenesis in 3T3-L1 cells through perturbation of mitotic clonal expansion. Gen. Comp. Endocrinol. 2013, 193:19-26.
225. Zucchetti A.E., Barosso I.R., Boaglio A.C., Basiglio C.L., Misczuk G., Larocca M.C., Ruiz M.L., Davio C.A., Roma M.G., Crocenzi F.A., Pozzi E.J. G protein-coupled receptor30-adenylyl cyclase-protein kinase A pathway is involved in estradiol 17ss-d-glucuronide-induced cholestasis. Hepatology 2013, [Epub ahead of print].